Disclaimer

Are you concerned about experiencing frailty as you age? 👵 Today’s study reveals that frailty in aging can potentially be ameliorated through intravenous administration of allogeneic human mesenchymal stem cells (hMSCs). 🧫 The treatment has demonstrated evident physiological and immunological improvements without any recorded adverse effects. 

Mesenchymal stem cells (MSCs) have once again been proven as a safe and well-tolerated approach for dealing with frailty. 👩‍🦳 In this study, they not only affect immunomodulation but also have a positive impact on the subjects' movement. 👍